BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018; 10(9): 585-594 [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Maraolo AE. Choosing the appropriate pharmacotherapy for hepatitis B during pregnancy: what are the considerations? Expert Opin Pharmacother 2021;22:1083-6. [PMID: 33797300 DOI: 10.1080/14656566.2021.1909571] [Reference Citation Analysis]
2 Chen L, Yue P, Lamb KV, Zhang Y, Zhu R. Stigma in HBV-infected pregnant women in disclosed situations: Current status, influencing factors, and impacts on the quality of life. Appl Nurs Res 2020;56:151347. [PMID: 33280787 DOI: 10.1016/j.apnr.2020.151347] [Reference Citation Analysis]
3 Odetunmibi OA, Adejumo AO, Anake TA. Log-Linear Modelling of Effect of Age and Gender on the Spread of Hepatitis B Virus Infection in Lagos State, Nigeria. Open Access Maced J Med Sci 2019;7:2204-7. [PMID: 31456852 DOI: 10.3889/oamjms.2019.573] [Reference Citation Analysis]
4 Joshi SS, Gao S, Castillo E, Coffin CS. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up. Dig Dis Sci 2020;65:204-14. [PMID: 31376084 DOI: 10.1007/s10620-019-05745-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]